Showing posts with label Depression. Show all posts
Showing posts with label Depression. Show all posts

Tuesday, May 25, 2010

Robert Munsch Admits to Depression, Cocaine and Alcohol Abuse

Winnipeg Free Press

TORONTO - For more than 30 years, Robert Munsch has fascinated young readers with his unique stories that have made his books staples of any child's library.

But it is his latest story, one of admission to cocaine and alcohol addictions, that has become the most shocking and captivating one, a story not intended for his young "Munschkin" fans.

In a message titled "Note to Parents" posted on his website, the bestselling author admits he's been diagnosed as obsessive-compulsive and manic-depressive and has been through Alcoholics Anonymous type programs.

"Those challenges have led me to make some big mistakes," Munch says, without providing further details.

But in an interview with Global Television aired Saturday, Munsch admitted he is recovering from cocaine addiction treatment and alcoholism, adding he has been clean for about four months.

In his note to parents, Munsch, 64, wrote that his mental health and addiction problems are not a secret to his friends and family.

"They have been a big support to me over the years, and I would not have been able to do this without their love and understanding."

He goes on to say that he hopes that others will also understand and that "everyone will talk to their kids honestly, listen to them, and help them do their best with their own challenges."

In August 2008, Munsch suffered a stroke that briefly affected his ability to speak in normal sentences, a big challenge for a man who used to do about 50 storytelling gigs a year.

In an interview with The Canadian Press four months after the stroke, Munsch said he was unable to create new stories.

"I try to do poetry and make up stories and it doesn't work, and (the doctors) told me that I should probably wait for a year for that to come back,'' he said at the time.

Munsch also said that he planned to edit the whopping 51 book drafts he had on the go before his stroke.

Born in Pittsburgh, Penn., Munsch studied to be a Jesuit priest before he decided to work in preschools, where he got his start as a storyteller.

He moved to Canada in 1975 and four years later wrote his first book titled "Mud Puddle''. He's since written more than 50 books, including some best-known titles like "Love You Forever'' and "The Paper Bag Princess.''

His latest books are "Down the Drain" and "Roar" published in 2009.

He has sold more than 30 million copies worldwide.

Munsch was made a Member of the Order of Canada in 1999 and was inducted into Canada's Walk of Fame last September.

Wednesday, March 17, 2010

Combination Treatment May Help Depressed Alcoholics

Business Week

Taking antidepressant plus naltrexone improves odds of not drinking, researchers say

Combined treatment with the antidepressant Zoloft (sertraline) and the alcoholism drug naltrexone improves the likelihood that people with both major depression and alcohol dependence will be able to stop drinking, U.S. researchers report.

Their 14-week study of 170 patients found that 54 percent of those who received the combined alcohol treatment were able to stop drinking, compared with 21 to 28 percent for patients who received a placebo, Zoloft only, or naltrexone only.

The patients who received the combined treatment also went for a longer period of time before they started drinking again -- 61 days compared with 15 days for patients in the other groups.

The findings may prove an important advance in the treatment of patients with alcohol dependence and depression, said the University of Pennsylvania researchers, and should be of interest for programs like Alcoholics Anonymous.

"When depression and alcohol dependence occur together, each condition has a negative influence on the outcome of the other, so not only does this pairing of illnesses affect a lot of patients, it also makes the individual disorders worse," study author Helen Pettinati said in a news release. "Combining sertraline and naltrexone could be a practical approach for these patients because both have (U.S. Food and Drug Adminstration) approval."